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The adenylation (A) domains of nonribosomal
peptide synthetases (NRPSs) activate aryl acids or
amino acids to launch their transfer through the
NRPS assembly line for the biosynthesis of many
medicinally important natural products. In order to
expand the substrate pool of NRPSs, we developed
amethod based on yeast cell surface display to engi-
neer the substrate specificities of the A-domains.
We acquired A-domain mutants of DhbE that have
11- and 6-fold increases in kcat/Km with nonnative
substrates 3-hydroxybenzoic acid and 2-aminoben-
zoic acid, respectively and corresponding 3- and
33-fold decreases in kcat/Km values with the native
substrate 2,3-dihydroxybenzoic acid, resulting in
a dramatic switch in substrate specificity of up to
200-fold. Our study demonstrates that yeast display
can be used as a high throughput selection plat-
form to reprogram the ‘‘nonribosomal code’’ of A-
domains.
INTRODUCTION
Nonribosomal peptide synthetases (NRPSs) are large multifunc-
tional enzymes that synthesize peptide natural products
known as nonribosomal peptides (NRPs), which are structurally
diverse and possess many important medicinal activities (Cane
et al., 1998; Clardy andWalsh, 2004). The anticancer agent bleo-
mycin; the immunosuppresant cyclosporin; and the antibiotics
vancomycin, daptomycin, and capreomycin are all examples of
nonribosomal peptide drugs approved by the Food and Drug
Administration. Since NRPSs do not use the mRNA-templated
ribosomal machinery, they are not restricted to the 20 proteino-
genic amino acids and often contain D-amino acids as well as
unnatural a-amino acids. Other conspicuous features of NRPSs
include N-methylation and cyclization of the peptide backbone,
both of which serve to enhance proteolytic stability. NRPSs
utilize a modular architecture where each module is responsible
for the incorporation of one amino acid substrate into the final
molecule (Fischbach and Walsh, 2006; Sieber and Marahiel,92 Chemistry & Biology 20, 92–101, January 24, 2013 ª2013 Elsevier2005). An NRPS extension module is composed of three core
domains including a condensation (C) domain, an adenylation
(A) domain and a peptidyl carrier protein (PCP) domain, while
the initial loading module requires only the A and PCP domains.
The A-domain is responsible for the selection, activation, and
loading of its cognate amino acid substrate onto the downstream
PCP-domain where it is covalently attached via a thioester
linkage (Figure 1A). The thiol moiety from the PCP-domain is
not from cysteine but rather from the terminal thiol moiety of an
approximately 20 A˚ long phosphopantetheine (Ppant) cofactor
moiety that modifies a conserved serine residue of the PCP-
domain. Movements of the PCP-domain and the Ppant arm
deliver the amino acid substrates to the C-domain that catalyzes
peptide bond coupling between substrate molecules loaded on
neighboring modules. This leads to the elongation of the peptide
chain in the N/ C direction. NRPSs thus work in an assembly-
line fashion with the growing peptide chain being passed down-
stream from one module to the next until it reaches the last
module. The full-length peptide chain is released by a thio-
esterase domain, usually via macrocyclization, to afford the final
product.
A-domains are the gatekeepers of NRPSs since they are
responsible for selection of the appropriate carboxylic acid
substrate, which is usually an amino acid but can also be an
aryl acid as found in siderophore NRPs, a fatty acid for lipopep-
tide NRPs, or a hydroxy acid for peptide ester containing
NRPs (Gulick, 2009; Sieber and Marahiel, 2005). A-domains
are 55–60 kDa and contain a large N-terminal subdomain
and a small C-terminal subdomain with the active site located
at the domain interface. These proteins are conformationally
dynamic and exist in an open unliganded conformation as well
as two different closed ligand-bound conformations. The
carboxylic acid substrate binding pocket is lined by 10 residues
that comprise the first-shell interactions with the substrate and
define the ‘‘nonribosomal codes’’ that enable the in silico predic-
tion of A-domain substrate specificity (Challis et al., 2000; Sta-
chelhaus et al., 1999; von Do¨hren et al., 1999). A-domains cata-
lyze a two-step adenylation-thioesterification reaction; in the first
step, they bind the substrate acid and ATP to afford a ternary
complex and then catalyze their condensation to afford an inter-
mediate acyl-adenylate (Sikora et al., 2010) (Figure 1A).
Following release of pyrophosphate, the C terminus of the
A-domain undergoes an approximately 140 rigid body rotation,
which enables binding of the downstream PCP-domain andLtd All rights reserved
Figure 1. DhbE Catalyzed Aryl Acid Activation and the Yeast Selection Scheme to Change the Substrate Specificity of DhbE
(A) DhbE catalyzes the condensation of DHB 1 with ATP to form DHB-AMP 2. The activated DHB is then transferred to the ArCP domain of DhbB to form
a thioester conjugate 3with the Ppant group of ArCP. DhbE can also activate SA 4. SA-AMS conjugate 5 is a bisubstrate inhibitor of DhbE. Structures of 3-HBA 6
and 2-ABA 7 as examples of nonnative substrates of DhbE are also shown.
(B) Selection of the A-domain library displayed on the surface of yeast cells. AMS-biotin conjugated SA (8) is used in the model selection to test the binding of
wtDhbE on yeast cell surface with substrate-AMS conjugate. Compounds 9 and 10 have nonnative substrates 3-HBA 6 and 2-ABA 7 conjugated to AMS-biotin.
They were used in the selection of DhbE mutants by yeast cell surface display.
See also Figures S1–S14 and Tables S1 and S3.
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Reprogramming Adenylation Domain Specificityinsertion of the Ppant cofactor arm into the A-domain active site
(Gulick, 2009). Acylation of the Ppant moiety followed by release
of the thioacylated PCP and AMP completes the catalytic cycle.
Several strategies have been explored to modify the substrate
specificity of A-domains in NRPS assembly lines to incorporate
nonnative building blocks to synthesize analogs with improved
or alternate biological activities (Cane et al., 1998; Nguyen
et al., 2006). Domain swapping to produce chimeric proteins
was first used to alter A-domain specificity; however, this
approach suffers from nonoptimal interactions between noncog-
nate protein domains that often result in drastically reduced
catalytic turnover, as well as premature truncation of the nascent
peptide (Baltz, 2008; Fischbach et al., 2007; Robbel and
Marahiel, 2010; Stachelhaus et al., 1995). In an effort to alleviate
these problems, Walsh and coworkers used directed evolution
to improve the activity of chimeric assembly lines, which led to
nearly 10-fold improvements in catalytic activity (Fischbach
et al., 2007). A complimentary approach to reengineer A-domain
specificity preserving the native protein-protein interactions
within an NRPS module has been to use the nonribosomal
peptide code and, more recently, computational structure-
based redesign to rationally mutate residues important for
substrate recognition (Chen et al., 2009; Eppelmann et al.,
2002; Thirlway et al., 2012). In order to screen potential mutants
more comprehensively, Kelleher and co-workers developed
a novel workflow involving directed evolution to create a library
of 1,000 mutants based on the ‘‘nonribosomal peptide code’’
and mass spectrometry to measure the ability of the resulting
mutants to support production of novel NRPs (Evans et al.,
2011). In this study, we report amethod to engineer the substrate
specificity of A-domains by yeast cell surface display that
takes advantage of high throughput fluorescence-activated cell
sorting (FACS) for iterative rounds of selection of millions of
A-domain mutants.Chemistry & Biology 20, 9As a first step to test our method, we selected the A-domain of
DhbE as a model system due to the availability of its 2.15 A˚ X-ray
cocrystal structure with bound acyl-adenylate (May et al., 2002),
availability of active-site directed inhibitors (Miethke et al., 2006),
and detailed knowledge of the kinetic mechanism (Sikora et al.,
2010). DhbE is part of a three-module NRPS assembly line
comprising DhbE, DhbB, and DhbF responsible for the synthesis
of the siderophore bacillibactin in Bacillus subtilis (May et al.,
2001). DhbE activates 2,3-dihydroxybenzoic acid (DHB, 1) to
form the DHB-AMP acyl-adenylate 2 and transfers it to the aryl
carrier protein (ArCP) domain of DhbB (Figure 1A). Another
distinct advantage of DhbE is that it is not embedded in a multi-
domain NRPS but is a stand-alone protein, which loads the
carrier protein domain in DhbB in an intermolecular fashion.
Consequently, DhbE is amenable to kinetic characterization of
the entire adenylation-thioesterification reaction as one can
use stoichiometric amounts of its cognate ArCP domain of
DhbB to obtain catalytic turnover. By contrast, most previous
reports for A-domain engineering where kinetic data are given
have only measured the adenylation partial reaction, as catalytic
turnover was not possible with the given multidomain NRPS
protein, and thus do not report on the kinetically and functionally
relevant overall reaction (Chen et al., 2009; Eppelmann et al.,
2002).
RESULTS
Engineer A-Domain Specificity by Yeast Cell Surface
Display
Yeast cell surface display has been extensively used to engineer
the binding specificity of antibodies (Chao et al., 2006; Miller
et al., 2008). The yeast vector pCTCON2 expresses the antibody
library as a fusion to the yeast agglutinin protein Aga2p that is
attached through disulfide bonds to Aga1p protein as part of2–101, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 93
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Reprogramming Adenylation Domain Specificitythe yeast cell wall (Figure 1B). The yeast cell library is then incu-
bated with a fluorescently labeled antigen to allow the binding of
antigen molecules to the antibody displayed on the yeast
surface. FACS is then used to isolate yeast cells displaying anti-
body mutants with high affinities with the antigen. To test if yeast
selection can be used to engineer the substrate specificity of the
A-domains, we cloned DhbE into the pCTCON2 vector to display
the DhbE enzyme on the yeast cell surface. The Aga2p-DhbE
domain fusion also has a hemagglutinin (HA) tag and a Myc tag
at the N and C termini, respectively, of the A-domain to enable
the detection of A-domain displayed on the cell surface (Fig-
ure 1B). After inducing the yeast cell to express the Aga2p-
DhbE fusion, we incubated the cells with a mouse anti-HA anti-
body and a chicken anti-Myc antibody so that the antibodies
would bind to the peptide tags flanking DhbE on the cell surface.
Cells were then washed and incubated with a mixture of goat
antimouse antibody conjugated with Alexa Fluor 647 and goat
antichicken antibody conjugated with Alexa Fluor 488 to label
DhbE displayed on the cell surface with fluorophores. Flow cy-
tometry analysis of the yeast cells showed that more than 30%
of the cells were doubly labeled with Alexa Fluor 647 and 488 flu-
orophores, indicating efficient display of DhbE on the yeast cell
surface (Figure S1A available online).
Next, we needed to develop a method to fluorescently label
the yeast cells displaying A-domain mutants with desired
substrate specificity in order to select these cells from the
A-domain library by FACS. Given the relatively low affinity of A-
domains for their substrate acids (1 mM–1 mM) and inability to
attach a biotin moiety conveniently without drastically affecting
substrate binding affinity, we elected to design a chemical probe
to report substrate recognition of the A-domains on the yeast cell
surface that exploits the following: (1) the high affinity of
A-domains for their intermediate acyl-adenylate (acyl-AMP) as
a result of the bisubstrate nature of this intermediate that inter-
acts with both the acid and ATP substrate binding pockets, (2)
the ability to mimic the acyl-AMP and therefore generate a
chemically stable probe by isosteric replacement of the phos-
phate moiety for a sulfamate (acyl-AMS probe, wherein AMS
denotes adenosine monosulfamate, an isostere of AMP) (Ferre-
ras et al., 2005; Finking et al., 2003; Miethke et al., 2006; Somu
et al., 2006), (3) the potential to modify acyl-AMS probes at their
C-2 position for incorporation of a biotin moiety without compro-
mising binding affinity (Neres et al., 2008), and (4) the high
discrimination of acyl-AMS probes for their cognate A-domain
(Qiao et al., 2007). Based on these design principles we prepared
salicyl-AMS probe 8 with biotin attached to the C-2 atom of the
purine base through a long and flexible linker (Figure 1A; for
synthesis, see the Supplemental Information, Figures S5–S14,
and Table S3) to report the binding to DhbE on the surface of
yeast cells. Probe 8 contains salicylic acid (SA) rather than
DHB due to the oxidative instability of the catechol in DHB. We
incubated 8 and chicken anti-Myc antibody with yeast cells to
allow their bindingwith wtDhbE on the cell surface. After washing
the cell, a mixture of streptavidin-conjugated phycoerythrin (PE)
and antichicken antibody conjugated with Alexa Fluor 488 were
added to the cells to detect the binding of 8 and the anti-Myc
antibody to wtDhbE. Flow cytometry showed that more than
17% of the cell population was double positive with labeling of
both fluorophores, indicating that wtDhbE expressed on the94 Chemistry & Biology 20, 92–101, January 24, 2013 ª2013 Elseviercell surface was able to bind 8 (Figure S1B). Thus yeast cell
surface display can be used to select A-domains based on their
affinity with acyl-AMS probes.
Construct an A-Domain Library of DhbE for Yeast
Selection
To assess the substrate specificity of DhbE, we measured
the steady-state kinetics of the complete adenylation-thioester-
fication reaction catalyzed by DhbE using saturating con-
centrations of the ArCP domain of DhbB in a coupled assay
that measures release of pyrophosphate (PPi). During this assay,
PPi generated in the DhbE-catalyzed condensation reaction
between the aryl substrate and ATP is converted to Pi by inor-
ganic pyrophosphatase (Ehmann et al., 2000; Webb, 1992).
Subsequently, purine nucleoside phosphorylase catalyzes the
phosphorolysis of the chromogenic substrate 7-methylthiogua-
nosine that can be monitored at 360 nm. After catalyzing the first
round of aryl-AMP formation, DhbE remains inactive until the
aryl-AMP intermediate dissociates from the enzyme or is broken
down by the transfer to DhbB. Consequently, the rate of PPi
release catalyzed by DhbE is a measure of the combined rate
of aryl-AMP dissociation from the enzyme and aryl transfer to
ArCP. A previous study on EntE, a DhbE homolog in Escherichia
coli, which also activates DHB and loads it onto an ArCP,
showed that the rate of DHB transfer to ArCP is more than
100-fold faster than the dissociation of DHB-AMP from the
enzyme, due to the tight-binding nature of the intermediate
acyl-adenylate (Ehmann et al., 2000). We can therefore approx-
imate the rate of PPi release in the assay to that of substrate
transfer to the ArCP domain catalyzed by DhbE. Using the PPi
release assay, we determined the specificity constants (kcat/Km)
for 2,3-dihydroxybenzoic acid (DHB, 1), 2-hydroxybenzoic
(SA, 4), 3-hydroxybenzoic acid (3-HBA, 6), and 2-aminobenzoic
acid (2-ABA, 7) as 1,100, 140, 22, and 5.5 min1mM1, respec-
tively (Table 1). 3-HBA and 2-ABA exhibit 2% and 0.5% activity,
respectively, relative to the native substrate DHB. Based on
these results, we decided to use yeast cell surface display to
engineer DhbE so that it can preferentially activate 3-HBA and
2-ABA over DHB and accordingly synthesized the correspond-
ing acyl-AMS probes 9 and 10 (Figure 1A; see Supplemental
Information for synthesis). For comparative purposes, we also
measured the steady-state kinetic parameters of DhbE using
the conventional ATP-PPi exchange assay that only measures
the adenylation partial reaction. We demonstrated DhbE adeny-
lates 3-HBA and 2-ABA, but at much lower rates than its native
substrate DHB, and the relative trend in activity was identical
to that observed with the PPi release assay (Figure S2A).
The crystal structure of the DhbE A-domain in complex with
DHB has been solved (Figure 2A), and it reveals a set of 10
active-site residues of DhbE that serve as the specificity confer-
ring nonribosomal code for DHB recognition: Asn235, Tyr236,
Ser240, Ala277, Gln304, Gly306, Val329, Val337, Tyr 339, and
Lys519 (Figure 2B) (May et al., 2002). Among them, the amide
moiety of the Asn235 side chain is engaged in hydrogen-bonding
interactions with the 2-OH and 3-OH groups of DHB. The side
chain of Val337 is also in close distance (5.1 A˚) with the 2-OH
group of DHB. Outside the residues involved in the nonribosomal
code, the imidazole nitrogen of His234 is within hydrogen-
bonding distance with both the carboxylate and 2-OH groupsLtd All rights reserved
Table 1. PPi Release Rate of the Aryl Acid Adenylation Reaction Catalyzed by wtDhbE and Mutants
Enzyme and Substrate Km (mM) kcat (min
1) kcat/Km (min
1mM1)
Ratio of kcat/Km with the Same
Substrate (Mutant/wtDhbE)
wtDhbE
DHB 4.3 ± 0.4 4.61 ± 0.09 1,100
SA 14 ± 2.2 1.90 ± 0.07 140
3-HBA 25 ± 7.7 0.56 ± 0.02 22
2-ABA 62 ± 17 0.34 ± 0.03 5.5
KZ4(Trp234His)
DHB 3.5 ± 0.8 1.45 ± 0.08 410 0.37
SA 46 ± 4.8 0.84 ± 0.01 18 0.13
3-HBA 4.8 ± 0.7 1.14 ± 0.02 240 11
KZ12(Trp234His)
DHB 38 ± 12 1.25 ± 0.14 33 0.03
SA 56 ± 14 0.37 ± 0.03 6.6 0.047
2-ABA 3.5 ± 0.3 0.12 ± 0.01 34 6.2
See also Table S1.
Figure 2. Substrate Binding Site of DhbE
(A) Crystal structure of DhbE with the binding pocket of DHB shown in solid
ribbons and the rest of the protein in line ribbons (Protein Data Bank ID 1MD8)
(May et al., 2002).
(B) Detailed structure of DHB binding site showing key active-site residues as
the nonribosomal code for DHB recognition. Names of the residues random-
ized in the DhbE library are in red.
See also Figure S4.
Chemistry & Biology
Reprogramming Adenylation Domain Specificityof DHB, and the methyl side chain of Ala333 is in close proximity
(3.5 A˚) to the 2-OH of DHB (Figure 2B). Since we intended to
engineer DhbE to be specific for 3-HBA and 2-ABA, in which
the 2-OH substitution of DHB is replaced with a hydrogen
atom or an amino group, we focused on improving the interac-
tions between DhbE and the C-2 functional groups in the aryl
acid substrates. We thus randomized His234, Asn235, Ala333,
and Val337 in DhbE to construct an A-domain library with
a size of 53 106, large enough to cover all themutants in a library
with four randomized residues (1.6 3 105) (Table S2).
Yeast Cell Surface Display to Identify DhbEMutants that
Are Specific for 3-HBA Activation
We displayed the library on the surface of yeast cells and carried
out iterative rounds of selection with acyl-AMS probe 9 contain-
ing 3-HBA as the acyl moiety (Figure 1B). The yeast selection
followed the protocol developed by Wittrup and Miller with
some modifications (Chao et al., 2006; Miller et al., 2008). In
the first round of selection we incubated the yeast cell library
with 3 mM 9. After washing the cells to remove unbound probes,
yeast cells labeled with biotin were collected by magnetic beads
coated with streptavidin. The use of magnetic-activated cell
sorting (MACS) allowed selection of a large quantity of yeast cells
(1 3 1010) by binding to the biotinylated probe. The first round
of selection was to identify yeast cells based on the affinity of
probe 9 with the DhbE mutants displayed on the cell surface.
In the second round of selection, we bound the cells to anti-HA
and anti-Myc antibodies to enrich cells displaying full-length
DhbE in the library. Our DhbE was flanked by an N-terminal HA
tag and a C-terminal Myc tag when it was displayed as a fusion
with the Aga2 protein on the surface of yeast cells. Full-length
DhbE should have both tags intact and be bound to both anti-
HA and anti-Myc antibodies (Figure 1B). The two types of anti-
bodies on yeast cell surface were detected by an antichicken
antibody conjugated to Alexa Fluor 488 and an antimouse anti-
body conjugated to Alexa Fluor 647. We used FACS to collect
the top 20% of cells that were doubly labeled by the two fluoro-
phores to eliminate cells displaying DhbE with N- or C-terminalChemistry & Biology 20, 9truncations in the library (Figure 3B). In subsequent rounds of
selection and FACS sorting, library cells were bound to probe
9 and chicken anti-Myc antibody as the primary reagents, and
streptavidin-PE and antichicken antibody Alexa Fluor 488 as
secondary reagents. Sort gate covered the range of cells that
were the top 0.1%–1.0% in brightness for binding to 9 and the
anti-Myc antibody (Figures 3C–3E). We also increased the selec-
tion stringency by decreasing the concentration of 9 from 1 mM in
round 3 to 0.1 mM in round 5. We observed a steady increase in
the yeast cell population appearing at the diagonal of the flow
cytometry plot corresponding to the enrichment of doubly
labeled cells that displayed DhbE mutants with high affinity to
probe 9 (Figure 3).
After five rounds of selection with 9, 30 clones were
sequenced. Alignment with wtDhbE showed that clone KZ2 is
the dominant clone after yeast selection with 14 appearances
among the 30 sequenced clones (Table 2). All selected DhbE2–101, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 95
Figure 3. Sorting of the DhbE Library Displayed on the Yeast Cell Surface by Binding to Biotin-Linked 3-HBA-AMS 9
(A) Sorting with magnetic beads coated with streptavidin. Binding of cells to 9 and an anti-Myc antibody was analyzed by flow cytometry.
(B) FACS sorting by antibody binding to the HA and Myc tags flanking DhbE on the cell surface.
(C–E), FACS by binding to 9 and an anti-Myc antibody. Percentages of doubly labeled cells were shown in the flow cytometry plots. Red frames in the plots
represent the sorting gates used for the collection of yeast cells.
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Reprogramming Adenylation Domain Specificityclones have His234 mutated to a Trp residue, while Val337 is
invariable and unchanged from the wild-type sequence. There
is also a tendency for Ala333 to be unchanged, while it is re-
placed by Ser and Thr residues in some of the selected clones.
Asn235 is more flexible, with Ala in KZ2 as the most preferred
mutation. Other residues such as Ser, Thr, Cys, Val and Gln
were also selected at position 235 to bind to 9. We expressed
the DhbE mutants (KZ1–4) that appeared multiple times among
the sequenced clones and assayed their catalytic activities.
The ATP-PPi exchange assay showed that DhbE mutants
KZ1–3 have similar activities as wtDhbE for activation of
3-HBA to form 3-HBA-AMP while KZ4 catalyzes 3-HBA activa-
tion at a rate about 10-fold higher than wtDhbE and mutants
KZ1–3 (Figure S2B). Also, KZ4 has a Km of 4 mM with 3-HBA,
only slightly larger than the Km of wtDhbE with the native
substrate DHB (2.5 mM) (Table S1). We then tested the transfer
of 3-HBA to the ArCP domain of DhbB catalyzed by the DhbE
mutants. To our surprise, while wtDhbE gave about 10% loading
of the ArCP domain with 3-HBA after 30 min (Figure 4A), none of
the mutants could catalyze the loading of ArCP with 3-HBA (Fig-
ure 4B). These results confirm that the DhbE mutants from yeastTable 2. Alignment of DhbE Mutants Selected by Yeast Cell
Surface Display with AMS Conjugated Probes 9 and 10
wtDhbE
Number of
Times Selected
Residue Number
234 235 333 337
H N A V
Clones selected by 9
KZ1 6 W S A V
KZ2 14 W A A V
KZ3 4 W N S V
KZ4 2 W Q T V
KZ5 2 W Q S V
KZ6 1 W T A V
KZ7 1 W C A V
KZ8 1 W V A V
Clones selected by 10
KZ11 10 W D T R
KZ12 9 W D T K
See also Table S2.
96 Chemistry & Biology 20, 92–101, January 24, 2013 ª2013 Elsevierselection can recognize 3-HBA for the adenylation reaction
but that the mutants are unable to transfer the activated aryl
substrate to the ArCP.
We speculated that the His234Trp mutation, persistent in
mutants KZ1–4, might have a detrimental effect on substrate
loading to the ArCP. The crystal structure of DhbE in complex
with DHB and AMP shows the imidazole side chain of His234
directly interacting with the DHB carboxylate and the 2-OH
group (Figure 2B) (May et al., 2002). Furthermore, the His234
side chain shields the DHB substrate from a tunnel through
which the Ppant group of PCP may approach the DHB-AMP
intermediate for thioester formation. While the His234Trp muta-
tion was selected because it may improve the binding between
the DhbE mutants and the aryl acid substrate, the Trp side chain
may block access of the Ppant thiol to the DHB adenylate due to
its considerably larger size relative to His. To recover the ArCP
loading activity of the DhbE mutants, we mutated Trp234 in
KZ1–4 back to His and generated mutants KZ1–4(Trp234His).
The ATP-PPi exchange assay showed that all four mutants
catalyze 3-HBA adenylate formation, with KZ4(Trp234His) still
possessing the strongest activity among the mutant clones (Fig-
ure S2C). A MALDI assay showed that within 30 min, the
KZ4(Trp234His) mutant can load 60% of the ArCP with 3-HBA,
while other mutants and wtDhbE can load less than 10% of the
ArCP (Figure 4C). These results show that the Trp234His reverse
mutation enabled substrate transfer from mutant DhbE to the
ArCP domain of DhbB, and the KZ4 mutant with Trp234His
mutation is significantly more active in loading 3-HBA onto
ArCP than wtDhbE.
We then used the PPi release assay to characterize the
kinetics of KZ4 (Trp234His) for catalyzing 3-HBA activation and
transfer to the ArCP (Figure 5; Table 1). We found that KZ4
(Trp234His) has a Km of 4.8 mM and a kcat of 1.14 min
1 with
3-HBA. In comparison, wtDhbE has a Km of 25 mM with 3-HBA,
5.2-fold higher than KZ4 (Trp234His); and a kcat of 0.56 min
1,
2-fold less than KZ4 (Trp234His) with 3-HBA. This suggests
that DhbE mutants enriched by yeast selection with the
3-HBA-AMS probe 9 acquired higher binding affinity with the
nonnative substrate 3-HBA. As a result, the specificity constant
(kcat/Km) of KZ4 (Trp234His) with 3-HBA is 240 min
1mM1,
which is 11-fold higher than wtDhbE with 3-HBA. The kcat/Km
of KZ4 (Trp234His) with the native substrate DHB is
410 min1mM1, which is nearly 3-fold lower than wtDhbE withLtd All rights reserved
Figure 4. MALDI Analysis of Transfer of 3-HBA Substrate to the ArCP Domain Catalyzed by wtDhbE and the KZ4 Mutants
(A–C) Reactions were allowed to proceed for 30 min at room temperature. (A) wtDhbE has some activity of loading 3-HBA to the ArCP domain of DhbB. (B) KZ4
mutant is defective in 3-HBA loading to ArCP. (C) The KZ4 (Trp234His) mutant can efficiently load 3-HBA to ArCP.
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Reprogramming Adenylation Domain SpecificityDHB (Table 1). Thus, KZ4 (Trp234His) makes a nearly 30-fold
switch in substrate specificity.
Yeast Cell Surface Display to Identify DhbE Mutants
Specific for 2-ABA Activation
We also carried out selection with the same DhbE library dis-
played on yeast cell surface and the acyl-AMS probe 10 contain-
ing 2-ABA as the acylmoiety (Figure 1). After five rounds of selec-
tion following the same protocol as employed with probe 9, we
found that the yeast library converged to two very similar DhbE
mutants: KZ11 and KZ12 (Figure S3; Table 2). Both mutants
have His234 replaced by Trp, the same as the mutants from
the selection with probe 9. The two mutants also have identical
Asn235Asp and Ala333Thr mutations. The only difference
between these two mutants is that Val337 is mutated to Arg in
KZ11 and to Lys in KZ12. Initially selected KZ11 and KZ12 are
not active in transferring 2-ABA substrate to the ArCP domain
of DhbB, similar to mutants KZ1–4. However, when we mutated
Trp234 back to His, KZ11(Trp234His) and KZ12(Trp234His)
became catalytically active for loading 2-ABA to the ArCP.
The PPi release assay showed that KZ12 (Trp234His) has a Km
of 3.5 mM with the 2-ABA substrate, 18-fold lower than that of
wtDhbE with 2-ABA (62 mM) (Table 1). Due to the lower Km, the
kcat/Km of KZ12 (Trp234His) with 2-ABA (34 min
1mM1) is 6.2-
fold higher than that of wtDhbE with 2-ABA. The kcat/Km of KZ12
(Trp234His) with the native substrate DHB is 33 min1mM1,
which is nearly 33-fold lower than wtDhbE with DHB (Table 1).
As a result, KZ12 (Trp234His) makes a 206-fold switch in sub-
strate specificity. Kinetic analysis of KZ12 (Trp234His) showed
that the mutant has a kcat of 0.12 min
1, similar to that of
wtDhbE-catalyzed 2-ABA activation (0.34 min1) (Table 1); how-
ever this kcat value is considerably lower than the kcat of wtDhbE
with its native substrate, DHB (4.6 min1). This suggests that,
while yeast selection based on affinity binding with bisubstrate
analog probes may improve binding interactions between the
engineered enzyme and nonnative substrates to give a lower
Km, such affinity-based selection may not be able to improve
the kcat of the engineered enzyme with nonnative substrates.
DISCUSSION
In this study, we performed yeast selection on an A-domain
library to change the substrate specificities of the A-domains.Chemistry & Biology 20, 9The yeast selection enriched A-domain mutants with high bind-
ing affinities with the acyl-AMS probes. In this way, the selected
A-domain mutants may have better recognition of the nonnative
substrates and enable their loading onto the ArCP domains in the
NRPS assembly line. We demonstrated that yeast cell surface
display is a very efficient platform to identify A-domain mutants
with altered binding specificities using nonnative substrates
conjugated to AMS. In just five rounds of selection of a yeast
library of 5 3 106 clones, we were able to identify distinct sets
of DhbE mutants that can bind to probes 9 and 10, containing
3-HBA and 2-ABA as the acyl moieties, respectively.
We also found that the DhbE mutants from yeast selection
have Km values 5- to 18-fold lower than wtDhbE for binding to
the nonnative substrates 3-HBA and 2-ABA (Table 1). By
contrast, the kcat values of the DhbE mutants change very little
with KZ4 catalyzing 3-HBA transfer with a kcat 2-fold higher
than wtDhbE, and KZ12 catalyzing 2-ABA transfer with a kcat
2-fold lower than wtDhbE. These results suggest that the
improvement in catalytic efficiency (kcat/Km) of the A-domain
mutants with the nonnative substrates is mainly due to the
decrease in Km, an indication of better recognition of the nonna-
tive substrates by the enzyme active site. These results agree
with previous work on engineering catalytic antibodies that
showed tighter binding with the transition state analog by the
antibody does not lead to a higher turnover rate (kcat) of the cata-
lytic reactions (Baca et al., 1997).
Our work on DhbE engineering also shed light on the mecha-
nism of substrate transfer catalyzed by the A-domain. Yeast
selection of the A-domain library identified a His234Trp mutation
present in all the mutants (Table 2). The crystal structure of DhbE
in complex with DHB and AMP suggested that the Trp residue at
this position may provide better stacking interactions between
the indole ring of the Trp side chain and the carboxylate and
sulfonamide groups of the aryl-AMS conjugate (Figure 2B).
However, the His234Trp mutation may also block the access
of the Ppant group from the ArCP to the aryl-AMP formed at
the enzyme active site. This notion is supported by the recently
reported crystal structure of EntE, a homologous enzyme of
DhbE from E. coli., covalently tethered to the ArCP domain of
EntB, equivalent to the ArCP domain of DhbB, through a mecha-
nism-based inhibitor (Mitchell et al., 2012; Sundlov et al., 2012).
In the EntE-EntB structure, the Ppant arm of the EntB ArCP is in-
serted into the substrate binding site of the EntE A-domain in2–101, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 97
Figure 5. Kinetic Analysis of DHB and
3-HBA Transfer to ArCP by wtDhbE and KZ4
(Trp234His) Based on the PPi Release Assay
Michaelis-Menten plot to compare the initial
rates of PPi release catalyzed by wtDhbE and
KZ4(Trp234His) at varying concentrations of native
substrate DHB (A) and nonnative substrate 3-HBA
(B). Data are means ± ranges for at least three
determinations.
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to the A-domain (Figure S4) (Sundlov et al., 2012). The side chain
of His234 from EntE has to adopt a different conformation from
the corresponding His234 in the DhbE structure to allow the
Ppant group to extend into the EntE active site. A His234Trp
mutation places a large indole ring in the path of Ppant that
may block the entry of the Ppant group. Indeed, none of the
mutants we assayed with the His234Trp mutation could load
the aryl acid substrate onto the ArCP. We were able to recover
the transfer activity of the DhbE mutant by introducing a reverse
mutation to put His234 residue back in the DhbE mutants (Fig-
ure 4C; Table 1). This suggests that yeast selection is best
utilized to improve substrate recognition at the A-domain resi-
dues devoted to substrate binding, but is less useful in opti-
mizing A-domain kinetics. More structural and mechanistic
insights on A-domain catalysis would certainly guide the future
library design and selection.
Yeast selection of an A-domain library also provided new
insights on DhbE domain recognition of aryl acid substrates
(Ames and Walsh, 2010; Stachelhaus et al., 1999). Asn235 and
Val337 are the nonribosomal code residues that were random-
ized in the DhbE library. When the yeast library was screened
against probe 9 for 3-HBA activation, KZ4 with Asn235 replaced
by a Gln residue showed higher efficiency in adenylate formation
with 3-HBA (Table 2; Table S1). The Gln side chain is one CH2
group longer than the Asn side chain in wtDhbE. It may extend
further into the substrate binding pocket to fill the space that
used to be occupied by the 2-OH substitute of DHB. The amide
NH2 of the Gln residue may also form hydrogen bonds with the
3-OH group in 3-HBA (Figure 2B). Yeast selection with probe 9
also showed that Val337 is indispensable for binding to 3-HBA.
When the yeast library was selected for binding to probe 10,
Val337 is replaced by Lys or Arg with longer and positively
charged side chains (Table 2). The Lys and Arg residues at this
position may interact with the 2-NH2 group of 2-ABA. Ala333
was not assigned as a nonribosomal code residue for A-domain
binding with the aryl acid substrates (Ames and Walsh, 2010).
After yeast selection with AMS conjugates to 3-HBA or 2-ABA,
Ala333 was replaced with Ser or Thr residues with hydroxyl
side chains that may form hydrogen bonds with the 3-HBA
and 2-ABA substrates. Overall, our results demonstrate that
A-domains can be reprogrammed by protein engineering to
recognize nonnative substrates. It would be interesting to see if
the A-domain mutants we acquired in this study incorporate
3-HBA or 2-ABA substrates into the bacillibactin scaffold.98 Chemistry & Biology 20, 92–101, January 24, 2013 ª2013 Elsevier Ltd All rights reservedOnce the A-domain is engineered to
incorporate nonnative aryl or amino acid
substrates into the NRPS assembly line,nonnative substrates could be used for the synthesis of ‘‘unnat-
ural natural products.’’ A correlation could be drawn between
engineering NRPS A-domains and the engineering of tRNA
synthetases, which are also adenylation domains for amino
acid activation (Wang et al., 2006). When tRNA synthetases are
engineered to load unnatural amino acids on tRNA, they open
the gate for the incorporation of unnatural building blocks into
proteins. NRPS enzymes seem to be more discerning of nonna-
tive substrates than the ribosome for protein biosynthesis. While
early work showed that downstream modules may block the
elongation of peptide intermediates with the incorporation of
nonnative substrates (Pavela-Vrancic et al., 1999; Uguru et al.,
2004), more recent studies have successfully demonstrated
the ability of reprogrammed A-domains to incorporate nonnative
substrates into the final NRPs (Evans et al., 2011; Fischbach
et al., 2007; Thirlway et al., 2012).
The structural complexity of NRP natural products in many
cases is restrictive to the production of analogs with improved
medicinal activities by traditional synthetic chemistry. Histori-
cally, natural product analogs were generated by derivatization
of the parent natural product. Combinatorial biosynthesis offers
a complimentary method to generate analogs through genetic
engineering of the biosynthetic genes. Addition, deletion, or
replacement of genes in NRPS gene clusters has been used to
reprogram NRPS enzymatic assembly lines to produce new
analogs of the antibiotics surfactin, daptomycin, and echino-
mycin (Nguyen et al., 2006; Stachelhaus et al., 1995; Watanabe
et al., 2009). Similar approaches have also been used to recon-
figure closely related gene clusters of polyketide synthases to
generate analogs of the antibiotic erythromycin (McDaniel
et al., 1999; Pfeifer et al., 2001). We expect our method for engi-
neering NRPS A-domains should greatly expand the scope of
the chemical building blocks for the combinatorial biosynthesis
of NRPs. Engineered nonribosomal peptide synthesis can be
used in parallel with engineered ribosomal peptide synthesis
(Yamagishi et al., 2011) to generate peptide libraries of diverse
structures.
SIGNIFICANCE
We describe a powerful method based on yeast cell sorting
to engineer A-domain substrate specificity employing acyl-
AMS probes for affinity selection that enables one to screen
millions of mutants, which is three orders of magnitude
more than previously described. Using this method, we
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nonnative substrates. We envision that the yeast selection
platform can also be used to engineer A-domain specificity
with amino acids by selection with the corresponding
aminoacyl-AMS probes. Our results also provided insight
into the substrate transfer to the ArCP domain as the
His234Trp mutation was catalytically incompetent in the
thioesterification reaction, but fully active in the adenylation
partial reaction. Activity could be fully recovered by intro-
ducing the reverse mutation, and these results are con-
sistent with structural studies recently reported from Gulick
and co-workers (Sundlov et al., 2012).
EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures for full synthetic procedures,
cloning, and kinetic characterization of the A-domain mutants.
Yeast Display of the DhbE Library
DhbE library in pCTCON2 was chemically transformed into YB100 yeast cells
following published protocols with some modifications (Gietz and Schiestl,
1991; Gietz and Woods, 2002). Briefly, yeast cells were first cultured in
200 ml YPD (20 g dextrose, 20 g peptone, and 10 g yeast extract in 1 l deion-
ized H2O, sterilized by filtration) to an optical density 600 (OD600) around 0.5 at
30C. The cells were then pelleted at 3,500 rpm for 5 min. Cells were subse-
quently washed by 20 ml TE (100 mM Tris base, 10 mM EDTA, pH 8.0) and
20ml LiOAc-TE (100mM lithium acetate in TE), before resuspension in approx-
imately 800 ml LiOAc-TE. A typical transformation reaction contained a mixture
of 1 mg pCTCON2 plasmid DNA, 2 ml denatured single-stranded carrier
DNA from salmon testes (Sigma Aldrich), 25 ml resuspended yeast competent
cells, and 300 ml polyethylene glycol (PEG) solution (40% [w/v] PEG 3350 in
LiOAc-TE). In order to achieve a library size of 106, 30 transformations were
set up in parallel. A control was also prepared in which the pCTCON2 plasmid
was excluded. Both the transformation reactions and the control were incu-
bated at 30C for 1 hr and then at 42C for 20min. Cells in each transformation
were pelleted by centrifuging at 13,000 rpm for 30 s and resuspended in 20 ml
SDCAA medium (2% [w/v] dextrose, 6.7 g Difco yeast nitrogen base without
amino acids, 5 g Bacto casamino acids, 50 mM sodium citrate, and 20 mM
citric acid monohydrate in 1 l deionized H2O, sterilized by filtration). Yeast cells
were resuspended, pooled together into 1 l SDCAA medium and allowed to
grow at 30C over a 2-day period to an OD600 above 5. For long-term storage
of the yeast library, 20 ml of the yeast culture was aliquoted in 15% glycerol
stock and stored at 80C.
To titer transformation efficiency, 10 ml of the resuspended yeast transform-
ants from either the librarymix or control was serially diluted in SDCAAmedium
and plated on Trp- plates—20 g agar, 20 g dextrose, 5 g (NH4)2SO4, 1.7 g Difco
yeast nitrogen base without amino acids, 1.3 g drop-out mix excluding Trp in
1 l deionized H2O, autoclaved. Yeast cells transformed with pCTCON2 plas-
mids were expected to appear within 2 days of incubation at 30C.
Model Selection of Yeast Cells Displaying wtDhbE
Yeast cell EYB100 was transformed with wild-type DhbE (wtDhbE) in
pCTCON2 and streaked on a Trp- plate. Yeast colonies grew up after two
days of incubation at 30C. Cells were scraped from the Trp- plate to inoculate
a 5 ml SDCAA culture that was allowed to shake at 30C to reach an initial
OD600 of 0.5. Cells were centrifuged at 3,000 rpm for 5 min and induced for
DhbE expression by resuspension in 5 ml SGCAA (2% [w/v] galactose, 6.7 g
Difco yeast nitrogen base without amino acids, 5 g Bacto casamino acids,
38 mM Na2HPO4 and 62 mM NaH2PO4 , H2O in 1 l deionized H2O, sterilized
by filtration). The yeast culture was shaken at 20C for 16–24 hr.
For analysis of DhbE display on the surface of yeast cells, 106 cells were
resuspended in 0.1 ml Tris-buffered saline (TBS) (25 mM Tris, pH 7.5,
150 mM NaCl) with 0.1% bovine serum albumin (BSA). Mouse anti-HA anti-
body (Santa Cruz Biotechnology, sc-7392) and chicken anti-c-myc antibody
(Invitrogen, A-21281) were used as primary antibodies, and they were added
to the cell suspension at a concentration of 10 mg/ml. The cells were incubatedChemistry & Biology 20, 9with antibodies for 45 min at 4C. The cells were then washed twice with 0.1%
BSA in TBS and stained with 5 mg/ml goat antimouse antibody conjugated with
Alexa Fluor 647 (Invitrogen A-21235) and goat antichicken antibody conju-
gated with Alexa Fluor 488 (Invitrogen, A-11039) in 0.1 ml 0.1% BSA in TBS.
The cell suspension was shielded from light and incubated at 4C for
30 min. After washing twice with 0.1% BSA in TBS, cells were analyzed on
a flow cytometer (LSRII, BD Biosciences) to count the number of cells that
were labeled with both fluorophores. Cells were also analyzed from control
labeling reactions in which primary antibodies were either excluded from the
reaction or cells were only labeled with primary and secondary antibodies
for just one of the affinity tags.
Cells displaying wtDhbEwere also assayed by binding to acyl-AMS probe 8.
During the labeling with primary reagents, 10 nM 8 and 10 mg/ml chicken anti-
c-myc antibody (Invitrogen, A-21281) were used. In the following step, 5 mg/ml
streptavidin conjugated with PE (Invitrogen, S-32350) and 5 mg/ml goat anti-
chicken antibody conjugated with Alexa Fluor 488 (Invitrogen, A-11039)
were used as secondary reagents for the detection of wtDhbE on the cell
surface and the binding of wtDhbE to 8.
Selection of the DhbE Library Displayed on the Yeast Cell Surface
The first round of selection of the yeast library was carried out with MACS. For
subsequent rounds of selection, FACS was used to identify yeast clones dis-
playing DhbE mutants that were bound to acyl-AMS probes 9 or 10 with high
affinity. For MACS selection, approximately 8 3 107 yeast cells displaying the
DhbE library were incubated with 9 or 10 in a total volume of 600 ml 0.1% BSA
in TBS. After 45 min at 4C with intermittent inversion to ensure thorough mix-
ing, cells were pelleted by centrifugation. Cells were then resuspended in fresh
0.1% BSA in TBS and pelleted again. This procedure was repeated twice to
remove biotin-linked affinity probe that was not bound to the yeast cells. After
washing, cells were mixed with 90 ml of streptavidin-coated microbeads
provided by the mMACS Streptavidin Starting Kit (Miltenyi Biotec, 130-091-
287) in a total volume of 800 ml of 0.1% BSA in TBS. Cell suspension was
shielded from light and incubated at 4C for 30 min. After the labeling reaction
was finished, the cells and magnetic beads were added to 30 ml of 0.1% BSA
in TBS. The cell suspension was pelleted by centrifugation at 500 g for 10 min.
The supernatant was aspirated, and the cell pellet including the magnetic
beads was resuspended in 500 ml 0.1% BSA-TBS. Yeast cells bound to
magnetic beads by biotin-streptavidin interaction were then captured by
a magnet according to manufacturer’s instructions, and the beads were
washed with 0.1% BSA in TBS. Cells bound to the magnetic beads were
eluted into 5 ml SDCAA medium supplemented with 100 mg/ml ampicillin
and 50 mg/ml kanamycin and were cultured at 30C overnight. In parallel,
library cells were bound to primary and secondary antibodies to evaluate the
display of DhbE mutants on the yeast cell surface.
The second-round selection of the yeast library was to enrich cells display-
ing full-length DhbE mutants. The library cells amplified from the first round
of selection were labeled with 10 mg/ml mouse anti-HA antibody (Santa
Cruz Biotechnology, sc-7392) and chicken anti-c-myc antibody (Invitrogen,
A-21281). After washing the cells, secondary antibodies of goat antimouse
antibody conjugated with Alexa Fluor 647 (Invitrogen, A-21235) and goat anti-
chicken antibody conjugated with Alexa 488 (Invitrogen, A-11039) were added
to the cells in 0.1%BSA in TBS. After incubation, cells were washed twice with
0.1% BSA in TBS. Cells with the top 15%–20% of brightness labeled by both
fluorophores were collected by FACS.
In subsequent rounds of yeast selection, cells were labeled with affinity
probes 9 or 10 and 4 mg/ml chicken anti-c-myc antibody (Invitrogen,
A-21281) as the primary reagents, and 5 mg/ml streptavidin-PE (Invitrogen,
S-32350) and 5 mg/ml goat antichicken antibody conjugated to Alexa Fluor
488 (Invitrogen, A-11039) as the secondary reagents. The labeling reaction
was incubated at 4C for 30 min; then cells were pelleted, washed twice,
and resuspended in TBS with 0.1% BSA for sorting. The concentration of
probe 9 or 10 was decreased from 1 mM in the third round of selection to
0.1 mM in the fifth round of selection. The sorting gate also becamemore strin-
gent with the top 0.1% of doubly labeled cells collected in the fifth round of
selection. After the fifth round of cell sorting, the collected cells were grown
in an SDCCA medium to an OD600 around 0.5. Zymoprep II Yeast Plasmid
Miniprep Kit (Zymo Research, D2004) was then used to extract pCTCON2
plasmid DNA from the yeast cells. The plasmids were then transformed into2–101, January 24, 2013 ª2013 Elsevier Ltd All rights reserved 99
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Reprogramming Adenylation Domain SpecificitySS320 E. coli competent cells. Individual colonies were miniprepped, and the
plasmid DNA was sequenced to reveal the selected mutations in the DhbE
clones. The DNA sequences of the mutant DhbE clones were aligned by the
ClustalW algorithm in the Lasergene MegAlign software (DNAStar).
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